Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dow Global Technologies LLC is a subsidiary of Dow Inc. that manages the parent company's extensive intellectual property portfolio and technology licensing operations. In the healthcare and life sciences sectors, the company focuses on materials science solutions, including pharmaceutical excipients, medical-grade polymers, and advanced packaging for medical devices. Their products, such as the AFFINISOL™ and ETHOCEL™ polymer lines, are critical for enhancing drug solubility and enabling controlled-release drug delivery systems. By leveraging deep expertise in chemistry and material engineering, Dow Global Technologies supports the development of more effective therapeutic delivery and high-performance healthcare infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dow Global Technologies.